These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27816494)

  • 1. Fragmentation in the biopharmaceutical industry.
    Goldsmith AD; Varela FE
    Drug Discov Today; 2017 Feb; 22(2):433-439. PubMed ID: 27816494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016.
    Gagnon MA; Volesky KD
    Global Health; 2017 Aug; 13(1):62. PubMed ID: 28830481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovator Organizations in New Drug Development: Assessing the Sustainability of the Biopharmaceutical Industry.
    Kinch MS; Moore R
    Cell Chem Biol; 2016 Jun; 23(6):644-53. PubMed ID: 27341432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sources of innovation for new medicines: questions of sustainability.
    Kinch MS; Kraft Z; Schwartz T
    Drug Discov Today; 2021 Jan; 26(1):240-247. PubMed ID: 33144150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The rational basis for the short-, medium-, and long-term evolution of the pharmaceutical industry].
    Amédée-Manesme O
    Therapie; 1999; 54(4):419-21. PubMed ID: 10667108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biopharmaceutical Innovation System in China: System Evolution and Policy Transitions (Pre-1990s-2010s).
    Hu H; Chung CC
    Int J Health Policy Manag; 2015 Sep; 4(12):823-9. PubMed ID: 26673466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent production is a prerequisite for successful exit of a biopharmaceutical company.
    Saotome C; Nakaya Y; Abe S
    Drug Discov Today; 2016 Mar; 21(3):406-9. PubMed ID: 26721189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macro-economic factors influencing the architectural business model shift in the pharmaceutical industry.
    Dierks RM; Bruyère O; Reginster JY; Richy FF
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):571-578. PubMed ID: 27653356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consolidation and maturation of the orthopaedic medical device market between 1999 and 2015.
    Piuzzi NS; Ng M; Song S; Bigach S; Khlopas A; Salas-Vega S; Mont MA
    Eur J Orthop Surg Traumatol; 2019 May; 29(4):759-766. PubMed ID: 30627923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant drug development, regulation, and commercialization: an Indian industry perspective.
    Sahoo N; Manchikanti P
    BioDrugs; 2011 Apr; 25(2):105-13. PubMed ID: 21230010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction and visualization of Mergers and Acquisitions using Economic Complexity.
    Arsini L; Straccamore M; Zaccaria A
    PLoS One; 2023; 18(4):e0283217. PubMed ID: 37011046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. As biotech turns 20..
    Miller HI
    Nat Rev Drug Discov; 2002 Dec; 1(12):1007-8. PubMed ID: 12461522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in the tissue engineering and stem cell industry "are we there yet?".
    Jaklenec A; Stamp A; Deweerd E; Sherwin A; Langer R
    Tissue Eng Part B Rev; 2012 Jun; 18(3):155-66. PubMed ID: 22220809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chapter 4. Transitions in pharmaceutical market, production and sales in Japan (1980-2010)].
    Yoshioka R; Matsumoto K
    Yakushigaku Zasshi; 2014; 49(1):64-76. PubMed ID: 25272638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anxieties of globalization: antidepressant sales and economic crisis in Argentina.
    Lakoff A
    Soc Stud Sci; 2004 Apr; 34(2):247-69. PubMed ID: 15297998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial drug discovery: is it all downhill from here?
    Projan SJ; Shlaes DM
    Clin Microbiol Infect; 2004 Nov; 10 Suppl 4():18-22. PubMed ID: 15522036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the pharmaceutical industry.
    Stave GM; Joines R
    Occup Med; 1997; 12(1):1-4. PubMed ID: 9153049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patent indicators: a window to pharmaceutical market success.
    Guo Y; Hu Y; Zheng M; Wang Y
    Expert Opin Ther Pat; 2013 Jul; 23(7):765-71. PubMed ID: 23611022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the obstacles in the pharma/biotech industry: 2009 update.
    Graul AI; Revel L; Tell M; Rosa E; Cruces E
    Drug News Perspect; 2010; 23(1):48-63. PubMed ID: 20155219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.